Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $1.48 and last traded at $1.46, with a volume of 43606 shares changing hands. The stock had previously closed at $1.45.
BioRestorative Therapies Price Performance
The stock has a market cap of $2.54 billion, a price-to-earnings ratio of -1.45 and a beta of 102.36. The firm has a fifty day moving average of $1.55 and a 200 day moving average of $1.62.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- The Significance of Brokerage Rankings in Stock Selection
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is a Bond Market Holiday? How to Invest and Trade
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
